nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Benzatropine—Benzphetamine—obesity	0.451	1	CrCrCtD
Hyoscyamine—Cyclandelate—CES1—obesity	0.00389	0.582	CrCbGaD
Hyoscyamine—Cyclopentolate—BCHE—obesity	0.000838	0.126	CrCbGaD
Hyoscyamine—Methylphenidate—SLC6A4—obesity	0.000708	0.106	CrCbGaD
Hyoscyamine—Dexmethylphenidate—SLC6A4—obesity	0.000708	0.106	CrCbGaD
Hyoscyamine—Cocaine—SLC6A4—obesity	0.000537	0.0804	CrCbGaD
Hyoscyamine—Erectile dysfunction—Sibutramine—obesity	0.000508	0.00145	CcSEcCtD
Hyoscyamine—Depression—Orlistat—obesity	0.000507	0.00145	CcSEcCtD
Hyoscyamine—Fatigue—Cimetidine—obesity	0.000506	0.00145	CcSEcCtD
Hyoscyamine—Constipation—Cimetidine—obesity	0.000502	0.00144	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Sibutramine—obesity	0.000497	0.00142	CcSEcCtD
Hyoscyamine—Muscle twitching—Topiramate—obesity	0.000497	0.00142	CcSEcCtD
Hyoscyamine—Depression—Sibutramine—obesity	0.00049	0.0014	CcSEcCtD
Hyoscyamine—Urticaria—Diethylpropion—obesity	0.00049	0.0014	CcSEcCtD
Hyoscyamine—Dizziness—Phenylpropanolamine—obesity	0.00049	0.0014	CcSEcCtD
Hyoscyamine—Diarrhoea—Phentermine—obesity	0.000485	0.00139	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Sibutramine—obesity	0.000485	0.00139	CcSEcCtD
Hyoscyamine—Abdominal distension—Bupropion—obesity	0.000484	0.00139	CcSEcCtD
Hyoscyamine—Feeling abnormal—Cimetidine—obesity	0.000484	0.00139	CcSEcCtD
Hyoscyamine—Myocardial infarction—Sibutramine—obesity	0.000482	0.00138	CcSEcCtD
Hyoscyamine—Dysphagia—Bupropion—obesity	0.000481	0.00138	CcSEcCtD
Hyoscyamine—Conjunctivitis—Sibutramine—obesity	0.000478	0.00137	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Topiramate—obesity	0.000471	0.00135	CcSEcCtD
Hyoscyamine—Sweating—Sibutramine—obesity	0.000471	0.00135	CcSEcCtD
Hyoscyamine—Vomiting—Phenylpropanolamine—obesity	0.000471	0.00135	CcSEcCtD
Hyoscyamine—Dizziness—Phentermine—obesity	0.000469	0.00134	CcSEcCtD
Hyoscyamine—Rash—Phenylpropanolamine—obesity	0.000467	0.00134	CcSEcCtD
Hyoscyamine—Dermatitis—Phenylpropanolamine—obesity	0.000467	0.00134	CcSEcCtD
Hyoscyamine—Body temperature increased—Cimetidine—obesity	0.000464	0.00133	CcSEcCtD
Hyoscyamine—Photophobia—Topiramate—obesity	0.000458	0.00131	CcSEcCtD
Hyoscyamine—Dry eye—Topiramate—obesity	0.000451	0.00129	CcSEcCtD
Hyoscyamine—Vomiting—Phentermine—obesity	0.000451	0.00129	CcSEcCtD
Hyoscyamine—Dysuria—Bupropion—obesity	0.00045	0.00129	CcSEcCtD
Hyoscyamine—Bradycardia—Sibutramine—obesity	0.000449	0.00129	CcSEcCtD
Hyoscyamine—Rash—Phentermine—obesity	0.000447	0.00128	CcSEcCtD
Hyoscyamine—Dermatitis—Phentermine—obesity	0.000447	0.00128	CcSEcCtD
Hyoscyamine—Headache—Phentermine—obesity	0.000444	0.00127	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Topiramate—obesity	0.000444	0.00127	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Bupropion—obesity	0.000443	0.00127	CcSEcCtD
Hyoscyamine—Nausea—Phenylpropanolamine—obesity	0.00044	0.00126	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Bupropion—obesity	0.000434	0.00124	CcSEcCtD
Hyoscyamine—Hypersensitivity—Cimetidine—obesity	0.000432	0.00124	CcSEcCtD
Hyoscyamine—Hypertonia—Topiramate—obesity	0.000428	0.00123	CcSEcCtD
Hyoscyamine—Hyperkinesia—Topiramate—obesity	0.000426	0.00122	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Bupropion—obesity	0.000423	0.00121	CcSEcCtD
Hyoscyamine—Diarrhoea—Diethylpropion—obesity	0.000422	0.00121	CcSEcCtD
Hyoscyamine—Nausea—Phentermine—obesity	0.000421	0.00121	CcSEcCtD
Hyoscyamine—Asthenia—Cimetidine—obesity	0.000421	0.00121	CcSEcCtD
Hyoscyamine—Myocardial infarction—Bupropion—obesity	0.00042	0.0012	CcSEcCtD
Hyoscyamine—Conjunctivitis—Bupropion—obesity	0.000417	0.00119	CcSEcCtD
Hyoscyamine—Sweating—Bupropion—obesity	0.000411	0.00118	CcSEcCtD
Hyoscyamine—Dizziness—Diethylpropion—obesity	0.000408	0.00117	CcSEcCtD
Hyoscyamine—Diarrhoea—Cimetidine—obesity	0.000402	0.00115	CcSEcCtD
Hyoscyamine—Mental disorder—Orlistat—obesity	0.0004	0.00114	CcSEcCtD
Hyoscyamine—Disorientation—Topiramate—obesity	0.000396	0.00113	CcSEcCtD
Hyoscyamine—Eczema—Topiramate—obesity	0.000394	0.00113	CcSEcCtD
Hyoscyamine—Arrhythmia—Sibutramine—obesity	0.000394	0.00113	CcSEcCtD
Hyoscyamine—Eye pain—Topiramate—obesity	0.000393	0.00112	CcSEcCtD
Hyoscyamine—Vomiting—Diethylpropion—obesity	0.000392	0.00112	CcSEcCtD
Hyoscyamine—Nasal congestion—Topiramate—obesity	0.000389	0.00111	CcSEcCtD
Hyoscyamine—Rash—Diethylpropion—obesity	0.000389	0.00111	CcSEcCtD
Hyoscyamine—Dysgeusia—Orlistat—obesity	0.000389	0.00111	CcSEcCtD
Hyoscyamine—Dermatitis—Diethylpropion—obesity	0.000389	0.00111	CcSEcCtD
Hyoscyamine—Dizziness—Cimetidine—obesity	0.000388	0.00111	CcSEcCtD
Hyoscyamine—Headache—Diethylpropion—obesity	0.000386	0.00111	CcSEcCtD
Hyoscyamine—Hallucination—Bupropion—obesity	0.000383	0.0011	CcSEcCtD
Hyoscyamine—Amnesia—Topiramate—obesity	0.000377	0.00108	CcSEcCtD
Hyoscyamine—Tension—Sibutramine—obesity	0.000377	0.00108	CcSEcCtD
Hyoscyamine—Dysgeusia—Sibutramine—obesity	0.000376	0.00108	CcSEcCtD
Hyoscyamine—Vision blurred—Orlistat—obesity	0.000374	0.00107	CcSEcCtD
Hyoscyamine—Nervousness—Sibutramine—obesity	0.000373	0.00107	CcSEcCtD
Hyoscyamine—Vomiting—Cimetidine—obesity	0.000373	0.00107	CcSEcCtD
Hyoscyamine—Thirst—Topiramate—obesity	0.000372	0.00107	CcSEcCtD
Hyoscyamine—Rash—Cimetidine—obesity	0.00037	0.00106	CcSEcCtD
Hyoscyamine—Dermatitis—Cimetidine—obesity	0.00037	0.00106	CcSEcCtD
Hyoscyamine—Headache—Cimetidine—obesity	0.000368	0.00105	CcSEcCtD
Hyoscyamine—Nausea—Diethylpropion—obesity	0.000366	0.00105	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Topiramate—obesity	0.000363	0.00104	CcSEcCtD
Hyoscyamine—Angioedema—Orlistat—obesity	0.000363	0.00104	CcSEcCtD
Hyoscyamine—Vision blurred—Sibutramine—obesity	0.000362	0.00104	CcSEcCtD
Hyoscyamine—Lethargy—Topiramate—obesity	0.000362	0.00104	CcSEcCtD
Hyoscyamine—Flushing—Bupropion—obesity	0.000357	0.00102	CcSEcCtD
Hyoscyamine—Vertigo—Orlistat—obesity	0.000357	0.00102	CcSEcCtD
Hyoscyamine—Hyponatraemia—Topiramate—obesity	0.000356	0.00102	CcSEcCtD
Hyoscyamine—Osteoarthritis—Topiramate—obesity	0.000354	0.00102	CcSEcCtD
Hyoscyamine—Agitation—Sibutramine—obesity	0.000353	0.00101	CcSEcCtD
Hyoscyamine—Angioedema—Sibutramine—obesity	0.000351	0.00101	CcSEcCtD
Hyoscyamine—Palpitations—Orlistat—obesity	0.000351	0.001	CcSEcCtD
Hyoscyamine—Nausea—Cimetidine—obesity	0.000349	0.000999	CcSEcCtD
Hyoscyamine—Psychotic disorder—Topiramate—obesity	0.000346	0.000991	CcSEcCtD
Hyoscyamine—Vertigo—Sibutramine—obesity	0.000345	0.000989	CcSEcCtD
Hyoscyamine—Syncope—Sibutramine—obesity	0.000345	0.000987	CcSEcCtD
Hyoscyamine—Convulsion—Orlistat—obesity	0.000344	0.000985	CcSEcCtD
Hyoscyamine—Arrhythmia—Bupropion—obesity	0.000344	0.000985	CcSEcCtD
Hyoscyamine—Palpitations—Sibutramine—obesity	0.00034	0.000973	CcSEcCtD
Hyoscyamine—Irritability—Topiramate—obesity	0.000338	0.000969	CcSEcCtD
Hyoscyamine—Chest pain—Orlistat—obesity	0.000338	0.000968	CcSEcCtD
Hyoscyamine—Loss of consciousness—Sibutramine—obesity	0.000338	0.000967	CcSEcCtD
Hyoscyamine—Mental disorder—Bupropion—obesity	0.000337	0.000966	CcSEcCtD
Hyoscyamine—Urinary retention—Topiramate—obesity	0.000337	0.000965	CcSEcCtD
Hyoscyamine—Anxiety—Orlistat—obesity	0.000337	0.000965	CcSEcCtD
Hyoscyamine—Ataxia—Topiramate—obesity	0.000333	0.000954	CcSEcCtD
Hyoscyamine—Convulsion—Sibutramine—obesity	0.000333	0.000954	CcSEcCtD
Hyoscyamine—Dry mouth—Orlistat—obesity	0.000331	0.000947	CcSEcCtD
Hyoscyamine—Dehydration—Topiramate—obesity	0.00033	0.000944	CcSEcCtD
Hyoscyamine—Tension—Bupropion—obesity	0.000329	0.000941	CcSEcCtD
Hyoscyamine—Dysgeusia—Bupropion—obesity	0.000328	0.00094	CcSEcCtD
Hyoscyamine—Chest pain—Sibutramine—obesity	0.000327	0.000937	CcSEcCtD
Hyoscyamine—Anxiety—Sibutramine—obesity	0.000326	0.000934	CcSEcCtD
Hyoscyamine—Nervousness—Bupropion—obesity	0.000325	0.000932	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Orlistat—obesity	0.000324	0.000928	CcSEcCtD
Hyoscyamine—Oedema—Orlistat—obesity	0.000324	0.000928	CcSEcCtD
Hyoscyamine—Hypokalaemia—Topiramate—obesity	0.000323	0.000924	CcSEcCtD
Hyoscyamine—Dry mouth—Sibutramine—obesity	0.00032	0.000916	CcSEcCtD
Hyoscyamine—Confusional state—Sibutramine—obesity	0.000316	0.000906	CcSEcCtD
Hyoscyamine—Vision blurred—Bupropion—obesity	0.000316	0.000904	CcSEcCtD
Hyoscyamine—Oedema—Sibutramine—obesity	0.000314	0.000898	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Sibutramine—obesity	0.000314	0.000898	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Orlistat—obesity	0.000313	0.000897	CcSEcCtD
Hyoscyamine—Shock—Sibutramine—obesity	0.000309	0.000884	CcSEcCtD
Hyoscyamine—Abdominal distension—Topiramate—obesity	0.000308	0.000883	CcSEcCtD
Hyoscyamine—Agitation—Bupropion—obesity	0.000308	0.000882	CcSEcCtD
Hyoscyamine—Dysphagia—Topiramate—obesity	0.000306	0.000877	CcSEcCtD
Hyoscyamine—Angioedema—Bupropion—obesity	0.000306	0.000877	CcSEcCtD
Hyoscyamine—Tachycardia—Sibutramine—obesity	0.000306	0.000877	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Sibutramine—obesity	0.000303	0.000868	CcSEcCtD
Hyoscyamine—Vertigo—Bupropion—obesity	0.000301	0.000862	CcSEcCtD
Hyoscyamine—Syncope—Bupropion—obesity	0.0003	0.00086	CcSEcCtD
Hyoscyamine—Angina pectoris—Topiramate—obesity	0.000298	0.000855	CcSEcCtD
Hyoscyamine—Palpitations—Bupropion—obesity	0.000296	0.000848	CcSEcCtD
Hyoscyamine—Loss of consciousness—Bupropion—obesity	0.000294	0.000843	CcSEcCtD
Hyoscyamine—Insomnia—Orlistat—obesity	0.000293	0.000839	CcSEcCtD
Hyoscyamine—Hypotension—Sibutramine—obesity	0.000293	0.000839	CcSEcCtD
Hyoscyamine—Convulsion—Bupropion—obesity	0.00029	0.000831	CcSEcCtD
Hyoscyamine—Dysuria—Topiramate—obesity	0.000286	0.00082	CcSEcCtD
Hyoscyamine—Dyspepsia—Orlistat—obesity	0.000285	0.000817	CcSEcCtD
Hyoscyamine—Chest pain—Bupropion—obesity	0.000285	0.000817	CcSEcCtD
Hyoscyamine—Anxiety—Bupropion—obesity	0.000284	0.000814	CcSEcCtD
Hyoscyamine—Insomnia—Sibutramine—obesity	0.000284	0.000812	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Topiramate—obesity	0.000282	0.000808	CcSEcCtD
Hyoscyamine—Dyspnoea—Sibutramine—obesity	0.00028	0.000801	CcSEcCtD
Hyoscyamine—Fatigue—Orlistat—obesity	0.000279	0.0008	CcSEcCtD
Hyoscyamine—Dry mouth—Bupropion—obesity	0.000279	0.000799	CcSEcCtD
Hyoscyamine—Somnolence—Sibutramine—obesity	0.000279	0.000798	CcSEcCtD
Hyoscyamine—Pain—Orlistat—obesity	0.000277	0.000794	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Topiramate—obesity	0.000276	0.000791	CcSEcCtD
Hyoscyamine—Dyspepsia—Sibutramine—obesity	0.000276	0.000791	CcSEcCtD
Hyoscyamine—Confusional state—Bupropion—obesity	0.000276	0.00079	CcSEcCtD
Hyoscyamine—Oedema—Bupropion—obesity	0.000273	0.000783	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Bupropion—obesity	0.000273	0.000783	CcSEcCtD
Hyoscyamine—Depression—Topiramate—obesity	0.000272	0.00078	CcSEcCtD
Hyoscyamine—Shock—Bupropion—obesity	0.000269	0.00077	CcSEcCtD
Hyoscyamine—Constipation—Sibutramine—obesity	0.000268	0.000768	CcSEcCtD
Hyoscyamine—Pain—Sibutramine—obesity	0.000268	0.000768	CcSEcCtD
Hyoscyamine—Feeling abnormal—Orlistat—obesity	0.000267	0.000765	CcSEcCtD
Hyoscyamine—Tachycardia—Bupropion—obesity	0.000267	0.000764	CcSEcCtD
Hyoscyamine—Conjunctivitis—Topiramate—obesity	0.000265	0.00076	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Orlistat—obesity	0.000265	0.000759	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Bupropion—obesity	0.000264	0.000757	CcSEcCtD
Hyoscyamine—Feeling abnormal—Sibutramine—obesity	0.000258	0.00074	CcSEcCtD
Hyoscyamine—Urticaria—Orlistat—obesity	0.000257	0.000737	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Sibutramine—obesity	0.000256	0.000734	CcSEcCtD
Hyoscyamine—Abdominal pain—Orlistat—obesity	0.000256	0.000734	CcSEcCtD
Hyoscyamine—Body temperature increased—Orlistat—obesity	0.000256	0.000734	CcSEcCtD
Hyoscyamine—Hypotension—Bupropion—obesity	0.000255	0.000732	CcSEcCtD
Hyoscyamine—Bradycardia—Topiramate—obesity	0.00025	0.000715	CcSEcCtD
Hyoscyamine—Urticaria—Sibutramine—obesity	0.000249	0.000714	CcSEcCtD
Hyoscyamine—Body temperature increased—Sibutramine—obesity	0.000248	0.00071	CcSEcCtD
Hyoscyamine—Abdominal pain—Sibutramine—obesity	0.000248	0.00071	CcSEcCtD
Hyoscyamine—Insomnia—Bupropion—obesity	0.000247	0.000708	CcSEcCtD
Hyoscyamine—Hallucination—Topiramate—obesity	0.000244	0.000699	CcSEcCtD
Hyoscyamine—Dyspnoea—Bupropion—obesity	0.000244	0.000698	CcSEcCtD
Hyoscyamine—Somnolence—Bupropion—obesity	0.000243	0.000696	CcSEcCtD
Hyoscyamine—Dyspepsia—Bupropion—obesity	0.000241	0.000689	CcSEcCtD
Hyoscyamine—Hypersensitivity—Orlistat—obesity	0.000239	0.000684	CcSEcCtD
Hyoscyamine—Fatigue—Bupropion—obesity	0.000236	0.000675	CcSEcCtD
Hyoscyamine—Pain—Bupropion—obesity	0.000234	0.00067	CcSEcCtD
Hyoscyamine—Constipation—Bupropion—obesity	0.000234	0.00067	CcSEcCtD
Hyoscyamine—Asthenia—Orlistat—obesity	0.000233	0.000666	CcSEcCtD
Hyoscyamine—Hypersensitivity—Sibutramine—obesity	0.000231	0.000662	CcSEcCtD
Hyoscyamine—Pruritus—Orlistat—obesity	0.000229	0.000657	CcSEcCtD
Hyoscyamine—Flushing—Topiramate—obesity	0.000228	0.000652	CcSEcCtD
Hyoscyamine—Feeling abnormal—Bupropion—obesity	0.000225	0.000645	CcSEcCtD
Hyoscyamine—Asthenia—Sibutramine—obesity	0.000225	0.000644	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Bupropion—obesity	0.000224	0.00064	CcSEcCtD
Hyoscyamine—Pruritus—Sibutramine—obesity	0.000222	0.000635	CcSEcCtD
Hyoscyamine—Diarrhoea—Orlistat—obesity	0.000222	0.000635	CcSEcCtD
Hyoscyamine—Urticaria—Bupropion—obesity	0.000217	0.000622	CcSEcCtD
Hyoscyamine—Abdominal pain—Bupropion—obesity	0.000216	0.000619	CcSEcCtD
Hyoscyamine—Body temperature increased—Bupropion—obesity	0.000216	0.000619	CcSEcCtD
Hyoscyamine—Mental disorder—Topiramate—obesity	0.000215	0.000615	CcSEcCtD
Hyoscyamine—Diarrhoea—Sibutramine—obesity	0.000215	0.000615	CcSEcCtD
Hyoscyamine—Dizziness—Orlistat—obesity	0.000214	0.000614	CcSEcCtD
Hyoscyamine—Erythema—Topiramate—obesity	0.000213	0.000611	CcSEcCtD
Hyoscyamine—Tension—Topiramate—obesity	0.000209	0.0006	CcSEcCtD
Hyoscyamine—Dysgeusia—Topiramate—obesity	0.000209	0.000599	CcSEcCtD
Hyoscyamine—Dizziness—Sibutramine—obesity	0.000207	0.000594	CcSEcCtD
Hyoscyamine—Nervousness—Topiramate—obesity	0.000207	0.000594	CcSEcCtD
Hyoscyamine—Vomiting—Orlistat—obesity	0.000206	0.00059	CcSEcCtD
Hyoscyamine—Rash—Orlistat—obesity	0.000204	0.000585	CcSEcCtD
Hyoscyamine—Dermatitis—Orlistat—obesity	0.000204	0.000585	CcSEcCtD
Hyoscyamine—Headache—Orlistat—obesity	0.000203	0.000581	CcSEcCtD
Hyoscyamine—Hypersensitivity—Bupropion—obesity	0.000201	0.000577	CcSEcCtD
Hyoscyamine—Vision blurred—Topiramate—obesity	0.000201	0.000576	CcSEcCtD
Hyoscyamine—Vomiting—Sibutramine—obesity	0.000199	0.000571	CcSEcCtD
Hyoscyamine—Rash—Sibutramine—obesity	0.000198	0.000566	CcSEcCtD
Hyoscyamine—Dermatitis—Sibutramine—obesity	0.000198	0.000566	CcSEcCtD
Hyoscyamine—Headache—Sibutramine—obesity	0.000196	0.000563	CcSEcCtD
Hyoscyamine—Asthenia—Bupropion—obesity	0.000196	0.000562	CcSEcCtD
Hyoscyamine—Agitation—Topiramate—obesity	0.000196	0.000562	CcSEcCtD
Hyoscyamine—Pruritus—Bupropion—obesity	0.000193	0.000554	CcSEcCtD
Hyoscyamine—Nausea—Orlistat—obesity	0.000192	0.000551	CcSEcCtD
Hyoscyamine—Vertigo—Topiramate—obesity	0.000192	0.000549	CcSEcCtD
Hyoscyamine—Syncope—Topiramate—obesity	0.000191	0.000548	CcSEcCtD
Hyoscyamine—Palpitations—Topiramate—obesity	0.000189	0.00054	CcSEcCtD
Hyoscyamine—Loss of consciousness—Topiramate—obesity	0.000188	0.000537	CcSEcCtD
Hyoscyamine—Diarrhoea—Bupropion—obesity	0.000187	0.000536	CcSEcCtD
Hyoscyamine—Nausea—Sibutramine—obesity	0.000186	0.000534	CcSEcCtD
Hyoscyamine—Convulsion—Topiramate—obesity	0.000185	0.00053	CcSEcCtD
Hyoscyamine—Chest pain—Topiramate—obesity	0.000182	0.00052	CcSEcCtD
Hyoscyamine—Anxiety—Topiramate—obesity	0.000181	0.000519	CcSEcCtD
Hyoscyamine—Dizziness—Bupropion—obesity	0.000181	0.000518	CcSEcCtD
Hyoscyamine—Dry mouth—Topiramate—obesity	0.000178	0.000509	CcSEcCtD
Hyoscyamine—Confusional state—Topiramate—obesity	0.000176	0.000503	CcSEcCtD
Hyoscyamine—Oedema—Topiramate—obesity	0.000174	0.000499	CcSEcCtD
Hyoscyamine—Vomiting—Bupropion—obesity	0.000174	0.000498	CcSEcCtD
Hyoscyamine—Rash—Bupropion—obesity	0.000172	0.000494	CcSEcCtD
Hyoscyamine—Dermatitis—Bupropion—obesity	0.000172	0.000493	CcSEcCtD
Hyoscyamine—Shock—Topiramate—obesity	0.000171	0.000491	CcSEcCtD
Hyoscyamine—Headache—Bupropion—obesity	0.000171	0.000491	CcSEcCtD
Hyoscyamine—Tachycardia—Topiramate—obesity	0.00017	0.000487	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Topiramate—obesity	0.000168	0.000482	CcSEcCtD
Hyoscyamine—Hypotension—Topiramate—obesity	0.000163	0.000466	CcSEcCtD
Hyoscyamine—Nausea—Bupropion—obesity	0.000162	0.000465	CcSEcCtD
Hyoscyamine—Insomnia—Topiramate—obesity	0.000158	0.000451	CcSEcCtD
Hyoscyamine—Dyspnoea—Topiramate—obesity	0.000155	0.000445	CcSEcCtD
Hyoscyamine—Somnolence—Topiramate—obesity	0.000155	0.000444	CcSEcCtD
Hyoscyamine—Dyspepsia—Topiramate—obesity	0.000153	0.000439	CcSEcCtD
Hyoscyamine—Fatigue—Topiramate—obesity	0.00015	0.00043	CcSEcCtD
Hyoscyamine—Constipation—Topiramate—obesity	0.000149	0.000427	CcSEcCtD
Hyoscyamine—Pain—Topiramate—obesity	0.000149	0.000427	CcSEcCtD
Hyoscyamine—Feeling abnormal—Topiramate—obesity	0.000144	0.000411	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Topiramate—obesity	0.000142	0.000408	CcSEcCtD
Hyoscyamine—Urticaria—Topiramate—obesity	0.000138	0.000396	CcSEcCtD
Hyoscyamine—Body temperature increased—Topiramate—obesity	0.000138	0.000394	CcSEcCtD
Hyoscyamine—Abdominal pain—Topiramate—obesity	0.000138	0.000394	CcSEcCtD
Hyoscyamine—Hypersensitivity—Topiramate—obesity	0.000128	0.000368	CcSEcCtD
Hyoscyamine—Asthenia—Topiramate—obesity	0.000125	0.000358	CcSEcCtD
Hyoscyamine—Pruritus—Topiramate—obesity	0.000123	0.000353	CcSEcCtD
Hyoscyamine—Diarrhoea—Topiramate—obesity	0.000119	0.000341	CcSEcCtD
Hyoscyamine—Dizziness—Topiramate—obesity	0.000115	0.00033	CcSEcCtD
Hyoscyamine—Vomiting—Topiramate—obesity	0.000111	0.000317	CcSEcCtD
Hyoscyamine—Rash—Topiramate—obesity	0.00011	0.000315	CcSEcCtD
Hyoscyamine—Dermatitis—Topiramate—obesity	0.00011	0.000314	CcSEcCtD
Hyoscyamine—Headache—Topiramate—obesity	0.000109	0.000313	CcSEcCtD
Hyoscyamine—Nausea—Topiramate—obesity	0.000103	0.000296	CcSEcCtD
Hyoscyamine—CHRM2—Signaling by GPCR—POMC—obesity	1.67e-05	8.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRL—obesity	1.67e-05	8.66e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STK11—obesity	1.67e-05	8.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STK11—obesity	1.66e-05	8.62e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL2—obesity	1.66e-05	8.61e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—LPL—obesity	1.66e-05	8.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL2—obesity	1.65e-05	8.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ESR1—obesity	1.65e-05	8.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLG—obesity	1.65e-05	8.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—RHOA—obesity	1.64e-05	8.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STK11—obesity	1.64e-05	8.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLG—obesity	1.64e-05	8.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—RHOA—obesity	1.64e-05	8.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL2—obesity	1.64e-05	8.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—F2—obesity	1.63e-05	8.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PRKCB—obesity	1.63e-05	8.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT2—obesity	1.63e-05	8.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3R1—obesity	1.63e-05	8.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLG—obesity	1.63e-05	8.44e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT2—obesity	1.62e-05	8.43e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—RHOA—obesity	1.62e-05	8.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3R1—obesity	1.62e-05	8.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GPX1—obesity	1.62e-05	8.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—BAD—obesity	1.61e-05	8.36e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT2—obesity	1.61e-05	8.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FOXO3—obesity	1.61e-05	8.34e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3R1—obesity	1.61e-05	8.34e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADRB2—obesity	1.6e-05	8.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FOXO3—obesity	1.6e-05	8.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADRB2—obesity	1.6e-05	8.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FOXO3—obesity	1.59e-05	8.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADRB2—obesity	1.58e-05	8.21e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SOCS1—obesity	1.58e-05	8.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CD36—obesity	1.58e-05	8.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SOCS1—obesity	1.57e-05	8.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CD—obesity	1.57e-05	8.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CD—obesity	1.56e-05	8.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SOCS3—obesity	1.56e-05	8.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CG—obesity	1.56e-05	8.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SOCS1—obesity	1.56e-05	8.09e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SOCS3—obesity	1.56e-05	8.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CD—obesity	1.55e-05	8.02e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IRS1—obesity	1.54e-05	8e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SOCS3—obesity	1.54e-05	7.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GNB3—obesity	1.53e-05	7.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GNB3—obesity	1.52e-05	7.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GNB3—obesity	1.51e-05	7.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—TYK2—obesity	1.51e-05	7.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CB—obesity	1.5e-05	7.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—TYK2—obesity	1.5e-05	7.79e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF2—obesity	1.5e-05	7.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CB—obesity	1.5e-05	7.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF2—obesity	1.5e-05	7.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—RHOA—obesity	1.49e-05	7.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—MTHFR—obesity	1.49e-05	7.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—RHOA—obesity	1.49e-05	7.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GNAS—obesity	1.49e-05	7.72e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—TYK2—obesity	1.49e-05	7.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—POMC—obesity	1.49e-05	7.71e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CB—obesity	1.48e-05	7.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GNAS—obesity	1.48e-05	7.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF2—obesity	1.48e-05	7.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3R1—obesity	1.48e-05	7.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—INS—obesity	1.48e-05	7.66e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—RHOA—obesity	1.47e-05	7.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3R1—obesity	1.47e-05	7.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GNAS—obesity	1.47e-05	7.62e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARA—obesity	1.46e-05	7.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.46e-05	7.57e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOB—obesity	1.46e-05	7.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL2—obesity	1.45e-05	7.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOB—obesity	1.45e-05	7.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOB—obesity	1.44e-05	7.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IGF1—obesity	1.43e-05	7.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT2—obesity	1.43e-05	7.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL5—obesity	1.42e-05	7.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGT—obesity	1.42e-05	7.36e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL5—obesity	1.42e-05	7.36e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL5—obesity	1.4e-05	7.28e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LPL—obesity	1.39e-05	7.22e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOE—obesity	1.39e-05	7.21e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LPL—obesity	1.39e-05	7.19e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FOXO1—obesity	1.38e-05	7.16e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RPS6KB1—obesity	1.38e-05	7.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CAV1—obesity	1.38e-05	7.14e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FOXO1—obesity	1.38e-05	7.14e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.37e-05	7.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOA1—obesity	1.37e-05	7.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LPL—obesity	1.37e-05	7.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CD—obesity	1.37e-05	7.12e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CB—obesity	1.36e-05	7.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FOXO1—obesity	1.36e-05	7.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RPS6KB1—obesity	1.36e-05	7.06e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CB—obesity	1.36e-05	7.06e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—obesity	1.36e-05	7.05e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SERPINE1—obesity	1.36e-05	7.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CB—obesity	1.35e-05	6.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TYK2—obesity	1.32e-05	6.85e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—RHOA—obesity	1.31e-05	6.79e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOS3—obesity	1.3e-05	6.72e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3R1—obesity	1.3e-05	6.72e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRKCD—obesity	1.28e-05	6.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRKCD—obesity	1.28e-05	6.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRKCD—obesity	1.26e-05	6.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—obesity	1.25e-05	6.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HTR2A—obesity	1.25e-05	6.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—C3—obesity	1.25e-05	6.5e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HTR2A—obesity	1.25e-05	6.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—C3—obesity	1.25e-05	6.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HTR2A—obesity	1.24e-05	6.42e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—C3—obesity	1.24e-05	6.41e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—obesity	1.23e-05	6.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—obesity	1.21e-05	6.28e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CB—obesity	1.2e-05	6.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MTOR—obesity	1.2e-05	6.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—POMC—obesity	1.19e-05	6.19e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IRS2—obesity	1.19e-05	6.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGT—obesity	1.19e-05	6.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IRS2—obesity	1.19e-05	6.16e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—INS—obesity	1.19e-05	6.16e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGT—obesity	1.19e-05	6.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IRS2—obesity	1.18e-05	6.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGT—obesity	1.17e-05	6.09e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LEP—obesity	1.17e-05	6.05e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOE—obesity	1.17e-05	6.05e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOE—obesity	1.16e-05	6.03e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LEP—obesity	1.16e-05	6.03e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CAV1—obesity	1.15e-05	5.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOA1—obesity	1.15e-05	5.98e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CAV1—obesity	1.15e-05	5.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LEP—obesity	1.15e-05	5.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOE—obesity	1.15e-05	5.97e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOA1—obesity	1.15e-05	5.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CAV1—obesity	1.14e-05	5.92e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOA1—obesity	1.14e-05	5.9e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ESR1—obesity	1.11e-05	5.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—obesity	1.11e-05	5.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ESR1—obesity	1.11e-05	5.76e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CD—obesity	1.1e-05	5.72e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—F2—obesity	1.1e-05	5.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRKCB—obesity	1.1e-05	5.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ESR1—obesity	1.1e-05	5.7e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRKCB—obesity	1.1e-05	5.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—F2—obesity	1.1e-05	5.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—obesity	1.09e-05	5.67e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—obesity	1.09e-05	5.65e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—BAD—obesity	1.09e-05	5.64e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—F2—obesity	1.09e-05	5.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRKCB—obesity	1.09e-05	5.63e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—BAD—obesity	1.08e-05	5.62e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—BAD—obesity	1.07e-05	5.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—obesity	1.05e-05	5.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—obesity	1.05e-05	5.44e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3R1—obesity	1.04e-05	5.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NOS3—obesity	1.04e-05	5.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IRS1—obesity	1.04e-05	5.4e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—obesity	1.04e-05	5.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—obesity	1.04e-05	5.39e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IRS1—obesity	1.04e-05	5.38e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IRS1—obesity	1.03e-05	5.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK8—obesity	1.01e-05	5.24e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—obesity	1.01e-05	5.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—POMC—obesity	1e-05	5.2e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—POMC—obesity	9.98e-06	5.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—INS—obesity	9.96e-06	5.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—INS—obesity	9.93e-06	5.15e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—POMC—obesity	9.88e-06	5.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—INS—obesity	9.83e-06	5.1e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL2—obesity	9.8e-06	5.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL2—obesity	9.77e-06	5.07e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL2—obesity	9.67e-06	5.02e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1—obesity	9.63e-06	5e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT2—obesity	9.62e-06	4.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CB—obesity	9.61e-06	4.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1—obesity	9.6e-06	4.98e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT2—obesity	9.59e-06	4.98e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—obesity	9.52e-06	4.94e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1—obesity	9.51e-06	4.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT2—obesity	9.5e-06	4.93e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CD—obesity	9.25e-06	4.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—obesity	9.24e-06	4.79e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CD—obesity	9.22e-06	4.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	9.16e-06	4.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SERPINE1—obesity	9.15e-06	4.75e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	9.13e-06	4.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CD—obesity	9.13e-06	4.74e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SERPINE1—obesity	9.12e-06	4.73e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	9.04e-06	4.69e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SERPINE1—obesity	9.03e-06	4.68e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TYK2—obesity	8.9e-06	4.62e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TYK2—obesity	8.87e-06	4.6e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RHOA—obesity	8.82e-06	4.58e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RHOA—obesity	8.8e-06	4.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TYK2—obesity	8.78e-06	4.56e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOS3—obesity	8.73e-06	4.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3R1—obesity	8.73e-06	4.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RHOA—obesity	8.71e-06	4.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3R1—obesity	8.7e-06	4.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOS3—obesity	8.7e-06	4.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3R1—obesity	8.62e-06	4.47e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOS3—obesity	8.62e-06	4.47e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—obesity	8.58e-06	4.45e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFB1—obesity	8.56e-06	4.44e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—obesity	8.32e-06	4.32e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—obesity	8.29e-06	4.3e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—obesity	8.21e-06	4.26e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CB—obesity	8.06e-06	4.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MTOR—obesity	8.06e-06	4.18e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MTOR—obesity	8.04e-06	4.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CB—obesity	8.04e-06	4.17e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CB—obesity	7.96e-06	4.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MTOR—obesity	7.96e-06	4.13e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—obesity	7.48e-06	3.88e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—obesity	7.46e-06	3.87e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—obesity	7.39e-06	3.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—obesity	7.37e-06	3.82e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—obesity	7.34e-06	3.81e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—obesity	7.29e-06	3.78e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—obesity	7.27e-06	3.77e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—obesity	7.01e-06	3.64e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—obesity	6.98e-06	3.62e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—obesity	6.92e-06	3.59e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK8—obesity	6.81e-06	3.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—obesity	6.8e-06	3.53e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK8—obesity	6.79e-06	3.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—obesity	6.77e-06	3.51e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK8—obesity	6.73e-06	3.49e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—obesity	6.71e-06	3.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—obesity	6.45e-06	3.35e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—obesity	6.23e-06	3.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—obesity	6.21e-06	3.22e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—obesity	6.15e-06	3.19e-05	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—obesity	5.95e-06	3.09e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—obesity	5.86e-06	3.04e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—obesity	5.79e-06	3e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFB1—obesity	5.77e-06	3e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—obesity	5.77e-06	2.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFB1—obesity	5.76e-06	2.99e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—obesity	5.71e-06	2.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFB1—obesity	5.7e-06	2.96e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—obesity	4.91e-06	2.55e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—obesity	4.9e-06	2.54e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—obesity	4.85e-06	2.52e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—obesity	4.79e-06	2.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—obesity	4.35e-06	2.26e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—obesity	4.34e-06	2.25e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—obesity	4.3e-06	2.23e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—obesity	4.01e-06	2.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—obesity	4e-06	2.08e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—obesity	3.96e-06	2.06e-05	CbGpPWpGaD
